DiscGenics, Inc.
675 Arapeen Drive
Suite 304
Salt Lake City
Utah
84108
United States
Tel: 801-410-0703
Fax: 801-581-3222
Website: http://www.discgenics.com/
Email: anthony@discgenics.com
32 articles about DiscGenics, Inc.
-
DiscGenics Announces First Patient Treated in U.S. Clinical Trial of IDCT for Degenerative Disc Disease
4/26/2018
DiscGenics, Inc. announced the first patient has been treated in its phase I/II U.S. clinical trial of IDCT for mild-to-moderate degenerative disc disease (DDD).
-
DiscGenics Presents Promising Preclinical Study Results at ORS 2018
3/22/2018
DiscGenics, Inc., a clinical stage regenerative medicine company focused on developing cell therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced it has presented results from two preclinical studies of IDCT at the Orthopedic Research Society (ORS) 2018 Annual Meeting, which was held last week in New Orleans, LA.
-
DiscGenics Joins MedCision's ThawSTAR Early Adopter Program for Cell Therapy Clinical Trials
11/1/2017
The program was initiated to help companies and investigators de-risk thawing of frozen cell therapies in early stage clinical trials through to commercialization and point-of-care.
-
DiscGenics, Inc. Receives FDA Allowance Of IND To Commence Clinical Study Of Its Degenerative Disc Disease Therapy
10/3/2017
-
DiscGenics, Inc. Raises $14 Million In Series B Financing
9/26/2017
-
DiscGenics, Inc. Fortifies Its Intellectual Property Portfolio With 9 Additional Patents
11/3/2016
-
DiscGenics, Inc. Recognized As Top 100 Company In North America By Red Herring
5/21/2014
-
BioLife Solutions, Inc. CryoStor® Adopted by DiscGenics, Inc. For Use In Novel, Injectable Cellular Therapy For Degenerative Disc Disease
12/9/2013
-
Dr. Kevin Foley to Present DiscGenics, Inc.'s Recent Findings at the Lumbar Spine Research Society's Annual Meeting
4/3/2013
-
DiscGenics, Inc. Successfully Completes Pilot Efficacy Study of Injectable Discosphere™ Cell Therapy
2/28/2013
-
DiscGenics, Inc. Receives "Notice of Issuance" on Its First U.S. Patent Application
7/25/2012
-
DiscGenics, Inc. Establishes its Development Phase Operations in Salt Lake City, Utah
6/28/2012